|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | myocardial 以后梗塞巨人让室的 pseudoaneurysm 与严重的心失败介绍显示文摘 Left ventricle(LV) pseudoaneurysm is a late mechanical complication of myocardial infarction.A giant LV pseudoaneurysm is a rare presentation.We report a case of giant LV pseudoaneurysm in a post-MI patient who presented with gross congestive heart failure.The patient had a successful surgical repair of the aneurysm and had a favorable 3-mo outcome.The imaging modality and surgical treatment of the pseudoaneurysm are discussed. | Rajesh Vijayvergiya Alok Kumar Sandeep S Rana Harkant Singh Goverdhan D Puri Manphool Singhal | 2012 | World Journal of Cardiology2012，4，11： | 3 |
| 2 | Interleukin-8 promoter polymorphism 251A/T is a risk factor for age-related macular degeneration 显示文摘 | Goverdhan SV Ennis S Hannan SR | 2008 | Br J Ophthalmol2008，92，4： | 1 |
| 3 | S6K1 promotes invasivenessof breast cancer cells in a model of metastasis of triple-negative breastcancer显示文摘 | Khotskaya YB Goverdhan A Shen J’ | 2014 | Am J Transl Res2014，6，4： | 1 |
| 4 | Differ-ential expression of MUC genes in endometrial and cervical tissuesand tumors显示文摘 | Vidya Hebbar Gautam Dameraand Goverdhan P Sachdev | 2005 | BMC Cancer2005，5，： | 1 |
| 5 | MUC1 regulates nu- clear localization and function of the epidermal growth factor显示文摘 | Bitler BG Goverdhan A Schroeder JA | 2010 | J Cell Sci2010，123，10： | 1 |
| 6 | Application of -cycloaddition in the synthesis of valdecoxib 显示文摘 | Reddy AR Goverdhan G Sampath A | 2012 | Synth Commun2012，42，5： | 1 |
| 7 | MUC1 regulates nuclear localization and function of the epidermal growth factor receptor显示文摘 | Bitler BG Goverdhan A Schroeder JA | 2010 | J Cell Sci2010，123，10： | 1 |
| 8 | Fixed bimonthly aflibercept in nave and switched neovascular age-related macular degeneration patients:one year outcomes显示文摘AIM: To determine real life clinical outcomes in poorly responsive and treatment-nave neovascular age-related macular degeneration(nv AMD) patients using bimonthly fixed dosing aflibercept regimen.METHODS: This was a retrospective study of 165 eyes with nv AMD started on aflibercept at Southampton Eye Unit between June 2013 and June 2014. Patients were either switched from pro re nata(PRN) ranibizumab/bevacizumab due to poor response(107 eyes), or treatment- nave( 58 eyes). Patients initially received 3-monthly intravitreal aflibercept injections followed by 2-monthly fixed doses. Clinic visits were scheduled at month 0, 4, 10 and 12. Mean change in best-corrected visual acuity(BCVA) and central retinal thickness(CRT)from baseline were assessed using the Wilcoxon signedrank test. The proportion of patients maintaining BCVA(<15 letters loss) at 12 mo was also evaluated.RESULTS: Mean BCVA change at month 12 was +3.29 and +4.67 letters in the switched and nave aflibercept groups respectively(P <0.01). BCVA was maintained in 95.3% of switched and 96.6% of nave patients. CRT at month 12 showed a decrease of -6.16 μm in the switched group and -35.36 μm in the nave group(P <0.01).Patients previously treated with ranibizumab/bevacizumab had on average received 7.4 ranibizumab/bevacizumab injections over 12.6 mo, attending 10 clinic visits. The fixed dosing aflibercept regimen required an average of 7.1 injections(nave group), 7.5 injections(switched group) and 4 clinic visits per year.CONCLUSION: Fixed bimonthly aflibercept is effective in both treatment-nave and poorly responsive nv AMD patients. Adopting a fixed dosing regimen can reduce patient burden without compromising on outcomes. | Alasdair N Warwick Hannah H Leaver Andrew J Lotery Srini V Goverdhan | 2016 | International Journal of Ophthalmology(English edition)2016，9，8： | 1 |
| 9 | Evaluation of closed‐loop anesthesia delivery for propofol anesthesia in pediatric cardiac surgery显示文摘 | Indranil Biswas Preethy J. Mathew Rana S. Singh Goverdhan D. Puri | 2013 | Paediatr Anaesth2013，，12： | 1 |
| 10 | Synthesis of Valganciclovir Hydrochloride Congeners显示文摘 | K.Srihari Babu M.Raghavendar Rao G. Goverdhan P. Srinivas P.Pratap Reddy G. Venkateswarlu R.Vijaya Anand | 2013 | Synthetic Communications2013，，13： | 1 |
| 11 | MUC1 regulates nuclear localization and function of the epidermal growth factor receptor 显示文摘 | Bider BG Goverdhan A Schroeder JA | 2010 | J Cell sci2010，123，10： | 1 |
| 12 | Functional group transformations of diols, cyclic ethers, and lactones using aqueous hydrobromic acid and phase transfer catalyst under microwaveIrradiation显示文摘 | Goverdhan L Kad | 2003 | Organic Process Research & Development2003，7，： | 1 |
| 13 | Complement factor H Y402H gene polymorphism in coronary artery disease and atherosclero- sis显示文摘 | Goverdhan S V Lotery A J Cree A J | 2006 | Atherosclerosis2006，188，1： | 1 |
| 14 | MUC1 regulates nuclear localization and function of the epidermal growth factor receptor显示文摘 | Bitler BG Goverdhan A Schroeder JA | | 0，，10： | 1 |
| 15 | An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment显示文摘 | Goverdhan SV Hannan S Newsom RB | 2008 | Eye2008，22，： | 1 |
| 16 | Ultrasound and microwave activated preparation of ZrO2-pillared clay composite: Catalytic activity for selective, solventless acylation of 1, n-diols 显示文摘 | VASUNDHARA Singh VARINDER Sapehiyia GOVERDHAN Lal Kad | 2004 | Journal of Molecular Catalysis A: Chemical2004，210，： | 1 |
| 17 | Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progres- sion of tractional retinal detachment 显示文摘 | Krishnan R Goverdhan S Lochhead J | 2009 | Eye ( Lond )2009，23，5： | 1 |
| 18 | Acidic ionic liquidsHSO4:an efficients catalyst for acetalization and thioacetalization of carbonyl compounds and their subsequent deprotection显示文摘 | Neeraj Gupta Sonu Goverdhan L | 2007 | Catal Commun2007，，8： | 1 |
| 19 | An Improved and Scalable Process for Celecoxib: A Selective Cyclooxygenase-2 Inhibitor显示文摘 | Reddy AR Sampath A Goverdhan G | 2009 | Org Process Res Dev2009，，： | 1 |
| 20 | Antibodies against hepatitis E virus in Old World monkeys显示文摘 | Arankalle VA Goverdhan MK Banerjee K | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员